Jack Meehan
Stock Analyst at Barclays
(3.91)
# 659
Out of 4,667 analysts
131
Total ratings
72.88%
Success rate
23.72%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $234 → $249 | $237.85 | +4.69% | 11 | Oct 25, 2024 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $128.57 | -2.78% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $357.77 | -19.50% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $20.14 | +63.85% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $131.68 | +146.81% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $18.24 | +4.17% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $161.32 | -38.63% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $203.67 | -11.62% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $15.30 | -34.64% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $194.38 | -14.60% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $78.04 | -44.90% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $187.90 | -18.04% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $323.69 | +32.84% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $334.85 | +28.42% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $37.48 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $53.37 | -10.06% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,166.90 | -41.73% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $109.61 | -72.63% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $512.84 | -41.50% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.33 | +2,898.73% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 25, 2024
Maintains: Equal-Weight
Price Target: $234 → $249
Current: $237.85
Upside: +4.69%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $128.57
Upside: -2.78%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $357.77
Upside: -19.50%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $20.14
Upside: +63.85%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $131.68
Upside: +146.81%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $18.24
Upside: +4.17%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $161.32
Upside: -38.63%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $203.67
Upside: -11.62%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $15.30
Upside: -34.64%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $194.38
Upside: -14.60%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $78.04
Upside: -44.90%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $187.90
Upside: -18.04%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $323.69
Upside: +32.84%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $334.85
Upside: +28.42%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $37.48
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $53.37
Upside: -10.06%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,166.90
Upside: -41.73%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $109.61
Upside: -72.63%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $512.84
Upside: -41.50%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.33
Upside: +2,898.73%